• Empowering you with objective information to assess pulmonary nodules.

  • Potentially avoiding biopsy or surgery – a reason to smile.

  • Simultaneously measures multiple proteins associated with lung cancer.

Xpresys Lung

Xpresys Lung is a molecular blood test developed to provide non-invasive, objective information for assessment of pulmonary nodules. When combined with current clinical assessment, Xpresys Lung may be able to help reduce unnecessary invasive procedures. By reducing these, our objectives are to improve patient outcomes, reduce complications, and lessen the cost to the healthcare system.

Learn more

Xpresys Lung is not affected by age, smoking history, gender, nodule size or nodule location. (1)

1. Li XJ et al, A blood-based proteomic classifier for the molecular characterization of pulmonary nodules. Sci. Transl. Med. 5, 207ra142 (2013).

Upcoming Events

October 3-5
HUPO World Congress
Speaker: Dr. Paul Kearney
October 25-30
CHEST 2104
Visit our booth #1731
Booth Presentation: Management of Indeterminate Pulmonary Nodules
Presenter: Dr. Alexander Porter

View all events

About Indi

Indi is creating powerful new tools to help physicians diagnose complex diseases with a non-invasive blood test. By measuring multiple biomarkers that serve as sentinels of disease – we are creating tests that help physicians diagnose disease states with greater accuracy.

Learn more

Good Work

Join Our Mailing List:

219 Terry Avenue North Suite 100

Seattle, WA 98109-5208

Phone: 206.576.6300

Fax: 206.576.6350


Xpresys Lung

Customer Support Phone:

855.977.3797 or 855.XPRESYS

Email: info@indidx.com

Follow Us

You are now leaving this website. If you would like to continue, click Continue.
Cancel Continue